| Mesalazine |
20130429 |
SALOFALK, -, 3000, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
94.15 |
18.83 |
112.98 |
4% |
3.77 |
97.92 |
19.58 |
117.5 |
16% |
15.06 |
112.98 |
22.6 |
135.58 |
Цената се заличава с решение НСР-4514/22.08.2014(допуска предварително изпълнение в сила от 22.08.2014) |
НСР-3935/30.06.2014 |
15.07.2014 |
15.07.2014 |
Заличен |
3038 |
| Mesalazine |
9600098 |
SALOFALK, Suppository, 500, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
31.49 |
6.3 |
37.79 |
4% |
1.26 |
32.75 |
6.55 |
39.3 |
16% |
5.04 |
37.79 |
7.56 |
45.35 |
|
НСР-3255/14.04.2014 |
29.04.2014 |
29.04.2014 |
Неактивен |
2747 |
| Mesalazine |
9600096 |
SALOFALK, Suppository, 250, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
15.86 |
3.17 |
19.03 |
6% |
0.95 |
16.81 |
3.36 |
20.17 |
18% |
2.85 |
19.66 |
3.93 |
23.59 |
Цената е заличена с решение НСР-3378/29.04.20014 |
НСР-3256/14.04.2014 |
29.04.2014 |
29.04.2014 |
Заличен |
2746 |
| Mesalazine |
II-0547/05.09.2007 |
SALOFALK, Suppository, 250, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
20.91 |
4.18 |
25.09 |
6% |
1.25 |
22.16 |
4.43 |
26.59 |
18% |
3.76 |
25.92 |
5.18 |
31.1 |
|
КЦРР-1054/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
2746 |
| Mesalazine |
II-0548/05.09.2007 |
SALOFALK, Suppository, 500, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
36.3 |
7.26 |
43.56 |
4% |
1.45 |
37.75 |
7.55 |
45.3 |
16% |
5.81 |
43.56 |
8.71 |
52.27 |
|
КЦРР-1054/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
2747 |
| Mesalazine |
II-0548/05.09.2007 |
SALOFALK, Suppository, 500, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
46 |
9.2 |
55.2 |
6% |
2.76 |
48.76 |
9.75 |
58.51 |
18% |
8.28 |
57.04 |
11.41 |
68.45 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
2747 |
| Mesalazine |
II-0547/05.09.2007 |
SALOFALK, Suppository, 250, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
21.69 |
4.34 |
26.03 |
8% |
1.74 |
23.43 |
4.69 |
28.12 |
20% |
4.34 |
27.77 |
5.55 |
33.32 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
2746 |
| Mesalazine |
9600067 |
SALOFALK, Gastro resistant tablet, 500, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
35.01 |
7 |
42.01 |
4% |
1.4 |
36.41 |
7.28 |
43.69 |
16% |
5.6 |
42.01 |
8.4 |
50.41 |
Промяна на обстоятелства НСР-13966/25.09.2017 |
КЦ-648/05.03.2009 |
19.03.2009 |
02.11.2017 |
Активен |
586 |
| Mesalazine |
II-0546/05.09.2007 |
SALOFALK, Gastro resistant tablet, 500, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
35.01 |
7 |
42.01 |
4% |
1.4 |
36.41 |
7.28 |
43.69 |
16% |
5.6 |
42.01 |
8.4 |
50.41 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
586 |
| Mesalazine |
20130427 |
SALOFALK, Gastro-resistant prolonged-release granules, 1000, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
106.85 |
21.37 |
128.22 |
4% |
4.27 |
111.12 |
22.22 |
133.34 |
16% |
17.1 |
128.22 |
25.64 |
153.86 |
|
НСР-9496/09.06.2016; НСР-12493/28.04.2017 |
13.05.2017 |
02.06.2017 |
Активен |
3760 |
| Mesalazine |
20130427 |
SALOFALK, Gastro-resistant prolonged-release granules, 1000, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
109.08 |
21.82 |
130.9 |
4% |
4.36 |
113.44 |
22.69 |
136.13 |
16% |
17.45 |
130.89 |
26.18 |
157.07 |
|
НСР-9496/09.06.2016 |
02.07.2016 |
02.07.2016 |
Неактивен |
3760 |
| Mesalazine |
20130427 |
SALOFALK, Gastro-resistant prolonged-release granules, 1000, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
109.08 |
21.82 |
130.9 |
4% |
4.36 |
113.44 |
22.69 |
136.13 |
16% |
17.45 |
130.89 |
26.18 |
157.07 |
|
НСР-3935/30.06.2014; НСР-5695/18.02.2015.; НСР-5936/01.04.2015.; НСР-9496/09.06.2016 |
02.07.2016 |
02.07.2016 |
Неактивен |
3760 |
| Mesalazine |
20130427 |
SALOFALK, Gastro-resistant prolonged-release granules, 1000, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
109.08 |
21.82 |
130.9 |
4% |
4.36 |
113.44 |
22.69 |
136.13 |
16% |
17.45 |
130.89 |
26.18 |
157.07 |
|
НСР-5936/01.04.2015.; НСР-9496/09.06.2016 |
02.07.2016 |
02.07.2016 |
Неактивен |
3760 |
| Mesalazine |
9600114 |
SALOFALK, Gastro resistant tablet, 250, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
17.5 |
3.5 |
21 |
6% |
1.05 |
18.55 |
3.71 |
22.26 |
18% |
3.15 |
21.7 |
4.34 |
26.04 |
|
КЦ-648/05.03.2009; НСР-9323/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
585 |
| Mesalazine |
II-0545/05.09.2007 |
SALOFALK, Gastro resistant tablet, 250, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
17.5 |
3.5 |
21 |
6% |
1.05 |
18.55 |
3.71 |
22.26 |
18% |
3.15 |
21.7 |
4.34 |
26.04 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
585 |
| Mesalazine |
20130428 |
SALOFALK, -, 1500, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
156.96 |
31.39 |
188.35 |
4% |
6.28 |
163.24 |
32.65 |
195.89 |
16% |
25 |
188.24 |
37.65 |
225.89 |
Цената се заличава с решение НСР-6798/23.07.2015 ( в сила от 16.08.2015) |
НСР-3935/30.06.2014 |
15.07.2014 |
15.07.2014 |
Заличен |
3037 |
| Mesalazine |
20130427 |
SALOFALK, -, 1000, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
130.85 |
26.17 |
157.02 |
4% |
5.23 |
136.08 |
27.22 |
163.3 |
16% |
20.94 |
157.02 |
31.4 |
188.42 |
НСР-5695/18.02.2015 |
НСР-3935/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3760 |
| Mesalazine |
20100771/30.11.2010 |
SALOFALK, Suppository, 1000, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma Germany |
19.05 |
3.81 |
22.86 |
6% |
1.14 |
20.19 |
4.04 |
24.23 |
18% |
3.43 |
23.62 |
4.72 |
28.34 |
корекц. Решение НСР-2592/24.01.2014 |
НСР-1893/27.11.2013; НСР-12567/05.05.2017; НСР-15008/08.02.2018 |
23.02.2018 |
02.03.2018 |
Активен |
2608 |
| Mesalazine |
20100771/30.11.2010 |
SALOFALK, Suppository, 1000, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma Germany |
21.69 |
4.34 |
26.03 |
6% |
1.3 |
22.99 |
4.6 |
27.59 |
18% |
3.9 |
26.89 |
5.38 |
32.27 |
корекц. Решение НСР-2592/24.01.2014 |
НСР-1893/27.11.2013; НСР-12567/05.05.2017 |
20.05.2017 |
02.06.2017 |
Неактивен |
2608 |
| Mesalazine |
9600068 |
SALOFALK, Suppository, 500, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
10.68 |
2.14 |
12.82 |
6% |
0.64 |
11.32 |
2.26 |
13.58 |
18% |
1.92 |
13.24 |
2.65 |
15.89 |
Промяна на обстоятелства НСР-13610/25.08.2017 |
НСР-7477/12.11.2015 |
27.11.2015 |
02.10.2017 |
Активен |
1303 |
| Mesalazine |
II-0548/05.09.2007 |
SALOFALK, Suppository, 500, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
10.68 |
2.14 |
12.82 |
6% |
0.64 |
11.32 |
2.26 |
13.58 |
18% |
1.92 |
13.24 |
2.65 |
15.89 |
|
НСР-7477/12.11.2015 |
27.11.2015 |
27.11.2015 |
Неактивен |
1303 |
| Mesalazine |
20100771/30.11.2010 |
SALOFALK, Suppository, 1000, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma Germany |
29.24 |
5.85 |
35.09 |
6% |
1.75 |
30.99 |
6.2 |
37.19 |
18% |
5.26 |
36.25 |
7.25 |
43.5 |
корекц. Решение НСР-2592/24.01.2014 |
НСР-1893/27.11.2013 |
11.02.2014 |
11.02.2014 |
Неактивен |
2608 |
| Mesalazine |
20100771/30.11.2010 |
SALOFALK, Suppository, 1000, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma Germany |
38.73 |
7.75 |
46.48 |
4% |
1.55 |
40.28 |
8.06 |
48.34 |
16% |
6.2 |
46.48 |
9.3 |
55.78 |
|
КЦРР-1273/21.08.2012 |
07.09.2012 |
07.09.2012 |
Неактивен |
2608 |
| Mesalazine |
II-0548/05.09.2007 |
SALOFALK, Suppository, 500, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
11.09 |
2.22 |
13.31 |
6% |
0.67 |
11.76 |
2.35 |
14.11 |
18% |
2 |
13.76 |
2.75 |
16.51 |
|
КЦРР-1054/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
1303 |
| Mesalazine |
II-0548/05.09.2007 |
SALOFALK, Suppository, 500, mg, Pack: 10 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
19.38 |
3.88 |
23.26 |
8% |
1.55 |
20.93 |
4.19 |
25.12 |
20% |
3.88 |
24.81 |
4.96 |
29.77 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1303 |